Erythropoietin disrupts hypoxia-inducible factor signaling in ovarian cancer cells

Gynecologic Oncology

Volumn 100, Issue 1, 2006, Pages 14-19

  Hale, Sarah A ^a,b   Wong, Cheung ^a,b   Lounsbury, Karen M ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cancer chemotherapy; HIF; Hypoxia; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN;

ARTICLE; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 29144479245     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.056     Document Type: Article

References (32)

1. J. Folkman Incipient angiogenesis J. Natl. Cancer Inst. 92 2000 94 95
2. G.L. Semenza HIF-1: using two hands to flip the angiogenic switch Cancer Metastasis Rev. 19 2000 59 65
3. E.K. Rofstad Microenvironment-induced cancer metastasis Int. J. Radiat. Biol. 76 2000 589 605
4. G.L. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia J. Appl. Physiol. 88 2000 1474 1480
5. J.W. Lee, S.H. Bae, J.W. Jeong, S.H. Kim, and K.W. Kim Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions Exp. Mol. Med. 36 2004 1 12
6. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732
7. C. Wong, T.L. Wellman, and K.M. Lounsbury VEGF and HIF-1a expression are increased in advanced stages of epithelial ovarian cancer Gynecol. Oncol. 91 2003 513 517
8. J.W. Fisher Erythropoietin: physiology and pharmacology update Exp. Biol. Med. (Maywood) 228 2003 1 14
9. D. Ribatti, M. Presta, A. Vacca, R. Ria, R. Giuliani, and P. Dell'Era Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Blood 93 1999 2627 2636
10. A.S. Stevenson, L. Cartin, T.L. Wellman, M.H. Dick, M.T. Nelson, and K.M. Lounsbury Membrane depolarization mediates phosphorylation and nuclear translocation of CREB in vascular smooth muscle cells Exp. Cell Res. 263 2001 118 130
11. T.L. Wellman, J. Jenkins, P.L. Penar, B. Tranmer, R. Zahr, and K.M. Lounsbury Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries FASEB J. 18 2004 379 381
12. Y. Dong, S.O. Lee, H. Zhang, J. Marshall, A.C. Gao, and C. Ip Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling Cancer Res. 64 2004 19 22
13. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
14. K.M. Lounsbury, A.L. Beddow, and I.G. Macara A family of proteins that stabilize the Ran/TC4 GTPase in its GTP-bound conformation J. Biol. Chem. 269 1994 11285 11290
15. C. Brahimi-Horn, N. Mazure, and J. Pouyssegur Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications Cell Signal 17 2005 1 9
16. J.A. Forsythe, B. Jiang, N.V. Iyer, F. Agani, S.W. Leung, and R.D. Koos Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1 Mol. Cell. Biol. 16 1996 4604 4613
17. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
18. G. Acs, P. Acs, S.M. Beckwith, R.L. Pitts, E. Clements, and K. Wong Erythropoietin and erythropoietin receptor expression in human cancer Cancer Res. 61 2001 3561 3565
19. Y. Yasuda, Y. Fujita, T. Matsuo, S. Koinuma, S. Hara, and A. Tazaki Erythropoietin regulates tumour growth of human malignancies Carcinogenesis 24 2003 1021 1029
20. F. Farrell, and A. Lee The erythropoietin receptor and its expression in tumor cells and other tissues Oncologist 9 Suppl 5 2004 18 30
21. H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, and M. Georgescu Modulation of hypoxia-inducible factor 1 expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res. 60 2000 1541 1545
22. Y.J. Jung, J.S. Isaacs, S. Lee, J. Trepel, and L. Neckers IL-1 beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J. 14 2003 2115 2117
23. D. Feldser, F. Agani, N.V. Iyer, B. Pak, G. Ferreira, and G.L. Semenza Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2 Cancer Res. 59 1999 3915 3918
24. P.J. Kallio, W.J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway J. Biol. Chem. 274 1999 6519 6525
25. A. Alfranca, M.D. Gutierrez, A. Vara, J. Aragones, F. Vidal, and M.O. Landazuri c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription Mol. Cell. Biol. 22 2002 12 22
26. Y. Mizukami, J. Li, X. Zhang, M.A. Zimmer, O. Iliopoulos, and D.C. Chung Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer Cancer Res. 64 2004 1765 1772
27. S.C. Santos, V. Lacronique, I. Bouchaert, R. Monni, O. Bernard, and S. Gisselbrecht Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway Oncogene 20 2001 2080 2090
28. C. Schmaltz, P.H. Hardenbergh, A. Wells, and D.E. Fisher Regulation of proliferation-survival decisions during tumor cell hypoxia Mol. Cell. Biol. 18 1998 2845 2854
29. T.J. Littlewood, E. Bajetta, J.W.R. Nortier, E. Vercammen, and B. Rapoport Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trail J. Clin. Oncol. 9 2001 2865 2874
30. M. Mittelman, A. Zeidman, P. Kanter, O. Katz, H. Oster, and D. Rund Erythropoietin has an anti-myeloma effect-A hypothesis based on a clinical observation supported by animal studies Eur. J. Haematol. 72 2004 155 165
31. G. Acs, M. Chen, X. Xu, P. Acs, A. Verma, and C.J. Koch Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells Cancer Lett. 214 2004 243 251
32. D.F. Silver, and M.S. Piver Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effect Gynecol. Oncol. 73 1999 280 284